Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Nature Communications|November 26, 2022
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidateKwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulinsLaetitia Misson Mindrebo, Hejun Liu, Gabriel Ozorowski, et al.
NPJ Vaccines|July 12, 2024
Priming antibody responses to the fusion peptide in rhesus macaquesChristopher A Cottrell, Payal P Pratap, Kimberly M Cirelli, et al.
Nature Communications|November 23, 2017
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 bindingDaniel W Kulp, Jon M Steichen, Matthias Pauthner, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Replaying germinal center evolution on a quantified affinity landscapeWilliam S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Iscience|August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathwaysFangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Cell|June 5, 2026
Replaying germinal center evolution on a quantified affinity landscapeWilliam S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Pageof 16